Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Belite Bio, Inc. ADR (BLTE) and BridgeBio Oncology Therapeutics (BBOT)TipRanks · 9 Sep 2026
Analysts Are Bullish on These Healthcare Stocks: EnGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)TipRanks · 9 Sep 2026
A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $70 to $125Market news · 9 Sep 2026
A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $70 to $111Market news · 8 Aug 2026
Jefferies Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)TipRanks · 8 Aug 2026
A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $97 to $145Market news · 7 Aug 2026
J.P. Morgan Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $100Market news · 17 Aug 2026
Morgan Stanley Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $126Market news · 10 Aug 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Oculis Holding (OCS), Stevanato Group (STVN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)TipRanks · 10 Aug 2026
Citi Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $97Market news · 10 Aug 2026
J.P. Morgan Maintains Structure Therapeutics(GPCR.US) With Buy RatingMarket news · 9 Jun 2026
Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $101Market news · 8 Jun 2026
Discussion
No comments yet — be the first to weigh in on GPCR.
No comments yet — be the first to weigh in on GPCR.